Heart Failure Management for Patient With CIED Remotely Monitored
NCT: NCT07247032 · RECRUITING
Brief Summary
This randomized, controlled, open-label, parallel, multicenter clinical study evaluates the efficacy of SmartSignalHF compared with heart failure (HF) remote monitoring (RM) standard of care in implanted patients with heart failure. The primary objective is to determine whether SmartSignalHF reduces all-cause mortality and HF hospitalizations at 12 months.
Frequently Asked Questions
What is Heart Failure Management for Patient With CIED Remotely Monitored?
Heart Failure Management for Patient With CIED Remotely Monitored is a clinical trial registered under NCT07247032. Current status: RECRUITING.
What is the status of NCT07247032?
The current status of NCT07247032 (Heart Failure Management for Patient With CIED Remotely Monitored) is: RECRUITING.
When did Heart Failure Management for Patient With CIED Remotely Monitored start?
Heart Failure Management for Patient With CIED Remotely Monitored started on 2025-12-19.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.